No Data
King International Shares Jump 14% on Withdrawal of Winding-up Petition
The "DeepSeek Moment" of medicine, has China’s Innovative Drugs also reached it?
Over the past four years, China's share of Global large-scale pharmaceutical Trade has surged from 5% to 30%. From research and development innovation to international mergers and acquisitions, Chinese Innovative Drugs companies are reshaping the Global pharmaceutical innovation landscape.
Express News | King International Investment - Petition Filed on Overdue Payment of RMB56.4 Mln Under Sales of Goods Agreement Dated 9 April 2024
KING INTL INV (00928) has received a liquidation petition.
KING INTL INV (00928) announced that the company has received a winding-up petition filed by Mianyang Zhongshang H.B. Fuller Distillery Co., Ltd. at...
Express News | King International Investment - Winding-up Petition Scheduled to Be Heard on 2 April 2025
Express News | King International Investment - Yan Ming Ceased to Be Co-Chairlady and Chief Executive Officer